Gilead Sciences EBITDA per Share 2011-2026 | GILD

Annual EBITDA per Share Gilead Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
8.35	1.64	6.38	6.1	8.16	3.47	4.48	7.42	11.8	14	15.9	10.7	3.19	2.83	2.64	2.35	3.97	2.97	2.37	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.9	1.64	6.25

Quarterly EBITDA per Share Gilead Sciences

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2	2010-Q1	2009-Q3	2009-Q2
2.16	2.75	2.06	1.87	-	0.79	2.2	-3.39	-	2.58	1.81	1.44	-	2.62	1.97	0.22	-	3.25	1.91	2.36	-	1.76	-2.27	1.96	-	-1.02	2.01	1.8	-	2.15	1.84	1.69	-	3.04	3.33	2.92	-	3.43	3.46	3.39	-	3.9	3.87	3.63	-	2.36	2.91	2	-	0.8	0.79	0.69	-	0.73	0.73	0.54	-	0.7	1.34	1.16	1.23	1.16	1.31	1.04	0.87

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
3.9	-3.39	1.72

EBITDA per Share of other stocks in the Biotechnology industry

Issuer	EBITDA per Share	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	-0.71	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	-15.2	-	2.43 %	$ 254 M	Germany
Coherus BioSciences CHRS	-1.54	$ 1.36	-4.23 %	$ 159 M	USA
Happiness Biotech Group Limited HAPP	-0.82	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	-2.35	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	0.08	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	-2.46	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	6.75	-	-	$ 40.3 B	USA
Genfit SA GNFT	-2.24	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-0.03	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	-0.87	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	-0.09	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	12.6	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	0.79	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	2.22	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-23.7	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	-3.51	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	-0.04	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	-0.03	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-0.03	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	-0.54	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	-7.17	$ 49.44	-3.96 %	$ 4.45 B	Schweiz
Институт стволовых клеток человека ISKJ	-2.69	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	-2.84	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	-1.81	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	-1.29	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	-4.28	$ 29.35	-0.84 %	$ 1.95 B	USA
Generation Bio Co. GBIO	-2.06	-	-	$ 344 M	USA
IMV IMV	-0.28	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	-4.25	-	-	$ 3.67 B	USA
Akouos AKUS	-2.45	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	-2.42	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	-3.85	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	-1.63	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	-1.67	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	-0.4	$ 14.95	2.57 %	$ 214 M	USA
Advaxis ADXS	-5.96	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-3.37	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	-6.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-0.36	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-3.89	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	-6.03	$ 2.82	-3.09 %	$ 4.64 M	Israel
Enlivex Therapeutics Ltd. ENLV	-0.32	$ 0.67	-2.89 %	$ 30.6 M	Israel
Aptose Biosciences APTO	0.01	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	-0.92	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-6.41	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	-3.02	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	-1.29	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	-0.09	$ 23.23	1.93 %	$ 2.96 B	USA
Allena Pharmaceuticals ALNA	-0.14	-	3.16 %	$ 1.9 M	USA